Silgan Holdings (SLGN) Misses Q2 EPS by 7c; cuts guidance

Silgan Holdings (NASDAQ: SLGN) reported Q2 EPS of $0.83, $0.07 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.55 billion.

GUIDANCE:

Silgan Holdings sees FY2023 EPS of $3.40-$3.60, versus the consensus of $3.98.

Silgan Holdings sees Q3 2023 EPS of $1.10-$1.20, versus the consensus of $1.35.

For earnings history and earnings-related data on Silgan Holdings (SLGN) click here.

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Tenon Medical (TNON) Misses Q2 EPS by 395c